Tara has a robust Intellectual Property practice focusing on complex patent litigation, counseling, and opinion work in the life sciences and pharmaceutical industries, with specific expertise in the Hatch-Waxman Amendments to the Food, Drug, and Cosmetic Act. Tara is also registered to practice before the U.S. Patent and Trademark Office.
Tara manages numerous cases, overseeing pre-suit strategy development, fact and expert discovery, pre-trial and trial phases, and federal appellate level proceedings. She has successfully handled both offense and defense in bench trials and preliminary injunction proceedings, with experience in examining key fact and expert witnesses. Tara has drafted and argued in support of or in opposition to numerous claim construction briefs, motions for summary judgment, motions to dismiss, and other substantive motions. She has also taken and defended numerous fact and expert depositions.
In addition to her litigation work, Tara drafts Petitions for Inter Partes Review and related proceedings. She also assists clients with contract negotiation and settlement and manages numerous due diligence and other patent counseling projects.
*Matter completed prior to joining Benesch.
Representative Experience
- Key member of trial team for a pharmaceutical company in ANDA litigation and on appeal with respect to numerous patents concerning an HIV antiviral.*
-
Key member of trial team that secured an invalidity ruling after appeal with respect to a patent in ANDA litigation concerning an ACE inhibitor.*
-
Key member of trial team that secured an invalidity ruling with respect to a patent in ANDA litigation concerning a steroid used to treat asthma.*
- Key member of team that secured victory on behalf of pharmaceutical company at the District Court and Federal Circuit levels, not only defeating a preliminary injunction motion but invalidating two patents upon summary judgment relating to a drug used to treat or prevent osteoporosis.*
- Member of team that secured a non-infringement ruling on summary judgment and on appeal with respect to a patent in ANDA litigation concerning a cephalasporin antibiotic.*
- Represented a pharmaceutical company in ANDA litigation involving numerous patents directed to a drug used to treat iron deficiency anemia in patients with chronic kidney disease (CKD).*
-
Represented pharmaceutical companies in ANDA litigation involving three polymorph patents relating to a coronary vasodilator used in pharmacologic stress testing.*
-
Represented pharmaceutical company in ANDA litigation involving formulation and device patents relating to a bronchodilator.*